Kudos to Dr. Bruce Siegel for his commentary in Modern Healthcare explaining why 340B savings should stay where they belong—with patients and communities. Allowing 340B savings "to revert to drug companies, or to go toward other uses, would pull the thread of the 340B program and unravel the fabric of essential health services for entire communities," writes Siegel, the … [Read more...]